Evolus, Inc.
EOLS$560M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEWPORT BEACH
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Aug 4, 2026
6wMarket Overview
Stock performance and key metrics
EOLS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Botulinum toxin, Type A
Glabellar Frown Lines
PrabotulinumtoxinA-Xvfs
Glabellar Frown Lines
Botulinum purified neurotoxin, Type A
Glabellar Frown Lines
DWP-450 (Botulinum purified neurotoxin, Type A)
Glabellar Frown Lines
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Botulinum toxin, Type A | Phase 3 | Glabellar Frown Lines | - | - |
PrabotulinumtoxinA-Xvfs | Phase 2 | Glabellar Frown Lines | - | - |
Botulinum purified neurotoxin, Type A | Phase 2 | Glabellar Frown Lines | - | - |
DWP-450 (Botulinum purified neurotoxin, Type A) | Phase 2 | Glabellar Frown Lines | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply